Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroendocrine differentiation in prostatic carcinoma: an update

P A di Sant'Agnese1

  • 1University of Rochester Medical Center, New York 14642, USA. pdisantagnese@pathology.rochester.edu

The Prostate. Supplement
|August 5, 1998
PubMed
Summary

Neuroendocrine differentiation in prostate cancer is linked to tumor growth and prognosis, particularly in androgen-insensitive types. Further research is needed to fully define its significance in prostatic carcinoma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2.

Cell death and differentiation·2008
Same author

Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments.

Annals of oncology : official journal of the European Society for Medical Oncology·2002
Same author

Calcitonin and calcitonin gene-related peptide in the human prostate gland.

The Prostate·2000
Same author

Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma.

The Prostate. Supplement·1998
Same author

Characterization of the cell-specific expression of parathyroid hormone-related protein in normal and neoplastic prostate tissue.

Urology·1998
Same author

Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects.

Urology·1998

Area of Science:

  • Oncology
  • Urology
  • Endocrinology

Background:

  • Neuroendocrine differentiation (NED) in prostatic carcinoma may influence prostate cancer growth and prognosis.
  • This is especially relevant for androgen-insensitive prostate tumors.

Purpose of the Study:

  • To review recent investigations on neuroendocrine differentiation in prostatic carcinoma.
  • To build upon previous review articles and provide an updated perspective.

Main Methods:

  • Systematic review of relevant publications on neuroendocrine differentiation in prostate cancer.
  • Analysis of new developments, including receptor detection and the role of neuroendocrine products.

Main Results:

  • New findings include detection of bombesin, calcitonin, and serotonin receptors.
  • Neuroendocrine products influence prostate cancer growth, invasiveness, and motility.
  • Prognostic significance appears greater in androgen-independent and metastatic tumors.

Conclusions:

  • Neuroendocrine differentiation in prostatic carcinoma holds significant potential.
  • Further definition is required to accurately assess its clinical significance.

Related Experiment Videos